InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,516.56
(
1.47%
)
US TECH 100
18,754.00
(
2.47%
)
Dow Jones
40,991.98
(
0.61%
)
Brent Oil
80.76
(
2.79%
)
Bitcoin
66,590.24
(
0.63%
)
Post# of 252753
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: AlpineBV_Miller post# 44415

Thursday, 04/05/2007 12:06:26 PM

Thursday, April 05, 2007 12:06:26 PM

Post# of 252753
ViRexx ... but think the company is cheap enough that a win in the OvaRex trials will make investors some money.
I agree with you. I think UTHR will do very well as well with OvaRex plus there is the Remodulin franchise so that's where my money is.

I was surprised that ViRexx didn't get some of the jump some of the other companies got following the DNDN panel outcome. Maybe because of all the other problems at the company and the fact that OvaRex isn't on too many people's radar screen. The IMPACT trials are PFS not overall survival too for what its worth.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up